Life After s Loss: Impact of Hepatitis B s Antigen Loss on Future Patient Outcomes
Daniel Q. Huang, Seng Gee Lim – 12 January 2021
NAFLD in Lean Asians
Mohammed Eslam, Fei Chen, Jacob George – 12 January 2021
Affordability of Antiviral Therapy in Asia‐Pacific Countries and Its Impact on Public Health Outcomes
Prowpanga Udompap, Tawesak Tanwandee, Rino Gani – 12 January 2021
Withdrawal of Nucleos(t)ide Analogues in Hepatitis B e Antigen–Negative Patients: An Asian Perspective
Tung‐Hung Su, Jia‐Horng Kao – 12 January 2021
CON: Liver Transplant Alone
Gina Choi – 12 January 2021
Hepatitis C Virus Elimination by 2030: Conquering Mount Improbable
Radha K. Dhiman, Madhumita Premkumar – 12 January 2021
Alcohol‐Associated Liver Disease: East Versus West
Phunchai Charatcharoenwitthaya, Suthat Liangpunsakul, Teerha Piratvisuth – 12 January 2021
Mast Cells Promote Nonalcoholic Fatty Liver Disease Phenotypes and Microvesicular Steatosis in Mice Fed a Western Diet
Lindsey Kennedy, Vik Meadows, Amelia Sybenga, Jennifer Demieville, Lixian Chen, Laura Hargrove, Burcin Ekser, Wasim Dar, Ludovica Ceci, Debjyoti Kundu, Konstantina Kyritsi, Linh Pham, Tianhao Zhou, Shannon Glaser, Fanyin Meng, Gianfranco Alpini, Heather Francis – 11 January 2021
Immune Checkpoint Inhibitors in Combinations for Hepatocellular Carcinoma
Sharanya Maanasi Kalasekar, Ignacio Garrido‐Laguna, Kimberley Jane Evason – 11 January 2021
Dual Agonist of Farnesoid X Receptor and Takeda G Protein‐Coupled Receptor 5 Inhibits Hepatitis B Virus Infection In Vitro and In Vivo
Kiyoaki Ito, Akinori Okumura, Junko S. Takeuchi, Koichi Watashi, Rieko Inoue, Taeko Yamauchi, Kazumasa Sakamoto, Yukiko Yamashita, Yusuke Iguchi, Mizuho Une, Takaji Wakita, Kazuo Umezawa, Masashi Yoneda – 11 January 2021